Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health
Sam Baker

FDA set to re-evaluate the safety and efficacy of long-term opioid use

FDA commissioner Scott Gottlieb. Photo: Drew Angerer/Getty Images

The Food and Drug Administration plans to require more research about whether opioid painkillers are safe for long-term use, per the Washington Post.

Between the lines: FDA Commissioner Scott Gottlieb told the Post, "We are going to impose a mandate on existing products ... to answer the question that people have been posing for years: whether you have declining efficacy, and whether that declining efficacy can lead to addiction." Former FDA commissioner David Kessler said on "60 Minutes" this past weekend that the agency made a mistake when it approved opioids like OxyContin for long-term use, because it didn't have enough scientific data to support that decision.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.